Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina A Guler

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Chest|January 10, 2026
Holding an ACE: Rethinking Angiotensin-Converting Enzyme Inhibitors and Survival in Pulmonary FibrosisSabina A Guler
Therapeutische Umschau. Revue Therapeutique|April 24, 2024
[Interstitial Lung Disease associated with Connective Tissue Diseases]Adela Sarbu, Sabina A Guler
Annals of the American Thoracic Society|December 1, 2021
Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung DiseasePankti Reid, Sabina A Guler
Respiration; International Review of Thoracic Diseases|November 20, 2018
Antifibrotics: Shrinking the Box of Therapeutic UncertaintySabina A Guler, Manuela Funke-Chambour
Current Opinion in Pulmonary Medicine|July 24, 2020
Frailty in patients with interstitial lung diseaseSabina A Guler, Christopher J Ryerson
Clinics in Chest Medicine|May 24, 2021
Interstitial Lung Disease in 2020: A History of ProgressSabina A Guler, Tamera J Corte
Current Opinion in Pulmonary Medicine|July 14, 2018
Unclassifiable interstitial lung disease: from phenotyping to possible treatmentsSabina A Guler, Christopher J Ryerson
Chest|June 12, 2025
Pulmonary Rehabilitation in Interstitial Lung Disease: Improving How Patients Feel, Function-and Potentially Survive?Sabina A Guler, Thomas F Riegler
Annals of the American Thoracic Society|November 27, 2024
Anchoring Patient Voices to Shape the Future of Patient-reported OutcomesAmanda Grant-Orser, Sabina A Guler
The European Respiratory Journal|April 1, 2023
The alternative approach: genomic classifiers for prognostication in interstitial lung diseaseGillian C Goobie, Sabina A Guler
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Chest|January 10, 2026
Holding an ACE: Rethinking Angiotensin-Converting Enzyme Inhibitors and Survival in Pulmonary FibrosisSabina A Guler
Therapeutische Umschau. Revue Therapeutique|April 24, 2024
[Interstitial Lung Disease associated with Connective Tissue Diseases]Adela Sarbu, Sabina A Guler
Annals of the American Thoracic Society|December 1, 2021
Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung DiseasePankti Reid, Sabina A Guler
Respiration; International Review of Thoracic Diseases|November 20, 2018
Antifibrotics: Shrinking the Box of Therapeutic UncertaintySabina A Guler, Manuela Funke-Chambour
Current Opinion in Pulmonary Medicine|July 24, 2020
Frailty in patients with interstitial lung diseaseSabina A Guler, Christopher J Ryerson
Clinics in Chest Medicine|May 24, 2021
Interstitial Lung Disease in 2020: A History of ProgressSabina A Guler, Tamera J Corte
Current Opinion in Pulmonary Medicine|July 14, 2018
Unclassifiable interstitial lung disease: from phenotyping to possible treatmentsSabina A Guler, Christopher J Ryerson
Chest|June 12, 2025
Pulmonary Rehabilitation in Interstitial Lung Disease: Improving How Patients Feel, Function-and Potentially Survive?Sabina A Guler, Thomas F Riegler
Annals of the American Thoracic Society|November 27, 2024
Anchoring Patient Voices to Shape the Future of Patient-reported OutcomesAmanda Grant-Orser, Sabina A Guler
The European Respiratory Journal|April 1, 2023
The alternative approach: genomic classifiers for prognostication in interstitial lung diseaseGillian C Goobie, Sabina A Guler
Pageof 6